Organization
Ji Xing Pharmaceuticals (Shanghai)
7 clinical trials
Clinical trial
An Open-Label Study of Aficamten for Chinese Patients With Symptomatic Obstructive Hypertrophic CardiomyopathyStatus: Recruiting, Estimated PCD: 2026-03-15
Clinical trial
A Single-Center, Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Phase I Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LNZ101 and LNZ100 Ophthalmic Solutions in Chinese Healthy Adult Subjects With PresbyopiaStatus: Completed, Estimated PCD: 2024-04-10
Clinical trial
A Single Center, Randomized, Double-Blind, Placebo-Controlled Phase 1 Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Etripamil in Healthy Chinese SubjectsStatus: Completed, Estimated PCD: 2023-03-26
Clinical trial
An Open-Label, Multiple-Dose Clinical Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of OC-01 (Varenicline Solution) Nasal Spray in Adult Chinese Subjects With Dry Eye DiseaseStatus: Completed, Estimated PCD: 2023-04-27
Clinical trial
A Multi-Center, Randomized, Double-Masked, Placebo-Controlled Phase 3 Evaluation of the Efficacy and Safety of LNZ101 and LNZ100 for the Treatment of PresbyopiaStatus: Recruiting, Estimated PCD: 2024-07-31
Clinical trial
A Phase 3, Multicenter, Randomized, Controlled, Double-Masked Clinical Trial to Evaluate the Efficacy and Safety of OC-01 (Varenicline Solution) Nasal Spray on Signs and Symptoms of Dry Eye Disease in Chinese PopulationStatus: Completed, Estimated PCD: 2023-04-04